Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (191-200 of 1,622) with videos related to

Pageof 163
Sort By:
Gynecologic Oncology|August 7, 2007
The dilemma of carboplatin-associated hypersensitivity reactions in ovarian cancer managementMaurie Markman
Cancer Journal (Sudbury, Mass.)|April 25, 2009
An update on the use of intraperitoneal chemotherapy in the management of ovarian cancerMaurie Markman
Gynecologic Oncology|July 1, 2008
Mandating prospectively defined endpoints for ovarian cancer phase 2 trials: a strategy to improve the quality of gynecologic cancer clinical researchMaurie Markman
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Supportive careMaurie Markman
Gynecologic Oncology|February 13, 2007
Re: "Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study"Maurie Markman
Gynecologic Oncology|January 30, 2007
The objectivity of reports describing the use of novel diagnostic tests in the management of ovarian cancer: a critiqueMaurie Markman
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
The role of intraperitoneal chemotherapy in ovarian cancerMaurie Markman
Current Pain and Headache Reports|July 13, 2006
Chemotherapy-induced peripheral neuropathy: underreported and underappreciatedMaurie Markman
Gynecologic Oncology|May 1, 2007
Platinum-based neoadjuvant chemotherapy for advanced ovarian cancerMaurie Markman
Gynecologic Oncology|July 10, 2010
Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factorsMaurie Markman
Pageof 163

Showing results (191-200 of 1,622) with videos related to

Sort By:
Pageof 163
Gynecologic Oncology|August 7, 2007
The dilemma of carboplatin-associated hypersensitivity reactions in ovarian cancer managementMaurie Markman
Cancer Journal (Sudbury, Mass.)|April 25, 2009
An update on the use of intraperitoneal chemotherapy in the management of ovarian cancerMaurie Markman
Gynecologic Oncology|July 1, 2008
Mandating prospectively defined endpoints for ovarian cancer phase 2 trials: a strategy to improve the quality of gynecologic cancer clinical researchMaurie Markman
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
Supportive careMaurie Markman
Gynecologic Oncology|February 13, 2007
Re: "Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study"Maurie Markman
Gynecologic Oncology|January 30, 2007
The objectivity of reports describing the use of novel diagnostic tests in the management of ovarian cancer: a critiqueMaurie Markman
Clinical Advances in Hematology & Oncology : H&O|December 5, 2006
The role of intraperitoneal chemotherapy in ovarian cancerMaurie Markman
Current Pain and Headache Reports|July 13, 2006
Chemotherapy-induced peripheral neuropathy: underreported and underappreciatedMaurie Markman
Gynecologic Oncology|May 1, 2007
Platinum-based neoadjuvant chemotherapy for advanced ovarian cancerMaurie Markman
Gynecologic Oncology|July 10, 2010
Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factorsMaurie Markman
Pageof 163